Eagle Bay Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,500
| Closed | -$51.3K | – | 472 |
|
|
2024
Q4 | $51.3K | Buy |
1,500
+100
| +7% | +$3.42K | 0.03% | 328 |
|
|
2024
Q3 | $57.8K | Hold |
1,400
| – | – | 0.02% | 417 |
|
|
2024
Q2 | $54.4K | Buy |
1,400
+100
| +8% | +$3.89K | 0.03% | 321 |
|
|
2024
Q1 | $56.3K | Hold |
1,300
| – | – | 0.04% | 290 |
|
|
2023
Q4 | $48.2K | Hold |
1,300
| – | – | 0.03% | 303 |
|
|
2023
Q3 | $47.1K | Hold |
1,300
| – | – | 0.02% | 419 |
|
|
2023
Q2 | $46.3K | Hold |
1,300
| – | – | 0.03% | 376 |
|
|
2023
Q1 | $46.3K | Sell |
1,300
-88
| -6% | -$3.13K | 0.03% | 399 |
|
|
2022
Q4 | $48.8K | Buy |
1,388
+700
| +102% | +$24.6K | 0.03% | 382 |
|
|
2022
Q3 | $20K | Buy |
688
+599
| +673% | +$17.4K | 0.01% | 508 |
|
|
2022
Q2 | $4.83K | Buy |
+89
| New | +$4.83K | ﹤0.01% | 709 |
|
|
2022
Q1 | – | Sell |
-185
| Closed | -$10K | – | 575 |
|
|
2021
Q4 | $10K | Sell |
185
-185
| -50% | -$10K | 0.01% | 673 |
|
|
2021
Q3 | $18K | Buy |
370
+210
| +131% | +$10.2K | 0.01% | 609 |
|
|
2021
Q2 | $8K | Buy |
+160
| New | +$8K | 0.01% | 702 |
|